Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases ; volume:39 ; number:5 ; day:22 ; month:3 ; year:2022 ; pages:2222-2235 ; date:5.2022
Advances in therapy ; 39, Heft 5 (22.3.2022), 2222-2235, 5.2022
- Creator
-
Kuwana, Masataka
Saito, Aiko
Sakamoto, Wataru
Raabe, Christina
Saito, Kumiko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02078-5
- URN
-
urn:nbn:de:101:1-2022071011121691390479
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuwana, Masataka
- Saito, Aiko
- Sakamoto, Wataru
- Raabe, Christina
- Saito, Kumiko
- SpringerLink (Online service)
Other Objects (12)
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Metabolomics in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Erosive Arthropathy in systemic sclerosis
TFH cells in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Interfacial Adipose Tissue in Systemic Sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Metabolomics in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Erosive Arthropathy in systemic sclerosis
TFH cells in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Interfacial Adipose Tissue in Systemic Sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Metabolomics in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Erosive Arthropathy in systemic sclerosis
TFH cells in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease